Treatment of erectile dysfunction using isoquinoline compound melanocortin receptor ligands
US6608082B1 · kind B1 · utility
4Cited by
17References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 6, 1999 |
| Grant date | Aug 19, 2003 |
| Priority date | — |
| Expiry date | May 6, 2019 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC40B40/00
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Methods for treating erectile dysfunction using tetrahydroisoquinoline aromatic amines that function as melanocortin receptor ligands.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.